Style | Citing Format |
---|---|
MLA | Shafaati M, et al.. "The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies." Heliyon, vol. 9, no. 3, 2023, pp. -. |
APA | Shafaati M, Bagherzadeh K, Lotfinia M, Karimi H, Teimoori A, Razazian M, Meidaninikjeh S, Hosseini H, Jamshidi HR, Jalili H, Abdoli A (2023). The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies. Heliyon, 9(3), -. |
Chicago | Shafaati M, Bagherzadeh K, Lotfinia M, Karimi H, Teimoori A, Razazian M, Meidaninikjeh S, et al.. "The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies." Heliyon 9, no. 3 (2023): -. |
Harvard | Shafaati M et al. (2023) 'The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies', Heliyon, 9(3), pp. -. |
Vancouver | Shafaati M, Bagherzadeh K, Lotfinia M, Karimi H, Teimoori A, Razazian M, et al.. The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies. Heliyon. 2023;9(3):-. |
BibTex | @article{ author = {Shafaati M and Bagherzadeh K and Lotfinia M and Karimi H and Teimoori A and Razazian M and Meidaninikjeh S and Hosseini H and Jamshidi HR and Jalili H and Abdoli A}, title = {The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies}, journal = {Heliyon}, volume = {9}, number = {3}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Shafaati M AU - Bagherzadeh K AU - Lotfinia M AU - Karimi H AU - Teimoori A AU - Razazian M AU - Meidaninikjeh S AU - Hosseini H AU - Jamshidi HR AU - Jalili H AU - Abdoli A TI - The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies JO - Heliyon VL - 9 IS - 3 SP - EP - PY - 2023 ER - |